The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.
News | FDA
Teleflex, and Arrow International, Recall Pressure Injectable Catheter Kits for Mislabeling

November 7, 2023 — The U.S. Food and Drug Administration (FDA) announced that Teleflex, and its subsidiary Arrow ...

Home November 07, 2023
Home
New add-on code goes into effect Jan. 1, 2024
News | Catheter
Centers for Medicare and Medicaid Services Establishes New Category I CPT Add-On Code for Coronary IVL

November 7, 2023 — Shockwave Medical, Inc, a pioneer in the development and commercialization of transformational ...

Home November 07, 2023
Home
the first patients in the United States have been treated successfully utilizing Abbott’s EnSite X EP System integrated with Stereotaxis’ Robotic Magnetic Navigation System
News | Robotic Systems
Abbott and Stereotaxis Technologies Used in First Integrated Procedures in the United States

November 7, 2023 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Home November 07, 2023
Home
Here's a look at what viewers found most interesting during the month of October on dicardiology.com
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
Top 10: What Viewers Were Reading in October

As another month comes to a close, DAIC takes a look at the Top 10 most-read pieces of content from www.dicardiology.com ...

Home November 06, 2023
Home
Artificial intelligence (AI) and deep learning models may help to predict the risk of cardiovascular disease events and detect heart valvular disease, according to two preliminary research studies.
News | Artificial Intelligence
AI May Accurately Detect Heart Valve Disease and Predict Cardiovascular Risk

November 6, 2023 — Advances in artificial intelligence have enabled the development and application of AI tools that may ...

Home November 06, 2023
Home
New clinical analyses and real-world data continue to demonstrate the benefit of treatment with CAMZYOS (mavacamten) for patients with symptomatic obstructive HCM
News | Cardiovascular Clinical Studies
Bristol Myers Squibb to Present Data from Innovative Cardiovascular Portfolio at the American Heart Association Scientific Sessions 2023

November 6, 2023 — Bristol Myers Squibb announced that research across the company’s cardiovascular franchise will be ...

Home November 06, 2023
Home
Study suggests CV risk factors and comorbidities could contribute to progression to dementia
News | Atrial Fibrillation
New Atrial Fibrillation Diagnosis May Increase risk of Memory Decline

November 6, 2023 — Atrial fibrillation (AF) diagnosis was associated with a 45% increased risk of mild cognitive ...

Home November 06, 2023
Home
Medical University of South Carolina researchers partner with Emergency Medical Services to pilot test the first MRI-equipped ambulance to speed stroke response
News | Stroke
An MRI-equipped Ambulance: A Game-changer for Stroke Care?

November 3, 2023 — In the U.S., someone has a stroke every 40 seconds and dies from it every three minutes and 14 ...

Home November 03, 2023
Home
Marlene Rabinovitch, MD, Stanford University
News | AHA
Dr. Marlene Rabinovitch to Receive the 2023 AHA Research Achievement Award

November 3, 2023 — The American Heart Association will present its 2023 Research Achievement Award to Marlene ...

Home November 03, 2023
Home
New Board of Cardiovascular Medicine will certify cardiovascular medicine physicians with more specific and more competency-based trainings and supports
News | Heart Failure
The American Heart Association Joins Consortium with Full Support for a New American Board of Cardiovascular Medicine

November 3, 2023 — The national Board of Directors of the American Heart Association last week voted to provide full ...

Home November 03, 2023
Home
DAIC VIVA23 Penumbra Flash Image
News | VIVA
Data from VIVA23 Late-breaking Clinical Trial Focuses on Computer-Assisted Vacuum Thrombectomy for Pulmonary Embolism

November 2, 2023 — The latest STRIKE-PE data, presented by Penumbra, Inc. at the Vascular Interventional Advances ...

Home November 02, 2023
Home
The University of Maryland Medical Center released a statement on the Oct. 30 passing of Lawrence Faucette, a 58-year-old patient with terminal heart disease who received the world’s second genetically-modified pig heart transplant Sept. 20 in a landmark cardiac xenotransplantation procedure.
News | Cardiovascular Surgery
UMMC Issues Statement on Passing of Man Who Received Second Pig Heart Transplant, Mourns Loss of Remarkable Patient, Scientist, Navy Veteran

November 2, 2023 — The University of Maryland Medical Center (UMMC) released a statement on the passing of a patient ...

Home November 02, 2023
Home
Results of the PERFORMANCE II Trial were presented by William Gray, MD, System Chief, Division of Cardiovascular Diseases, Main Line Health, and Co-National Principal Investigator during the VIVA23 annual conference..
News | VIVA
PERFORMANCE II Carotid Stent Trial One-Year Outcomes Released at VIVA23

November 2, 2023 — Contego Medical Inc. announced the presentation of late-breaking clinical results from the ...

Home November 02, 2023
Home
DAIC VIVA23 Heart image
News | VIVA
VIVA23 Presents Outcomes of Late-breaking Science from Abbott’s LIFE-BTK, RESOLV FIH Study, and IN.PACT AV Access Trial

November 2, 2023 — The second round of late-breaking clinical trials results from the Vascular InterVentional Advances ...

Home November 01, 2023
Home
DAIC VIVA 23 logo
News | VIVA
Vascular InterVentional Advances Conference, VIVA23, Clinical Trial Outcomes: PROMISE II (LimFlow) Trial for TADV, PRELUDE Study (LimbSonic) Therapeutic Ultrasound Presented

November 1, 2023 — The VIVA Foundation has announced the results for the first Late-Breaking Clinical Trial sessions at ...

Home November 01, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now